Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Vaccitech plc
  6. Summary
    VACC   US91864C1071

VACCITECH PLC

(VACC)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nasdaq
09/10/2021 09/13/2021 09/14/2021 09/15/2021 09/16/2021 Date
15.6(c) 15.505(c) 15.97(c) 16.11(c) 16.5(c) Last
10 456 13 839 18 518 21 867 47 480 Volume
+3.04% -0.61% +3.00% +0.88% +2.42% Change
More quotes
Estimated financial data (e) (USD)
Sales 2021 24,7 M - -
Net income 2021 -37,1 M - -
Net cash position 2021 156 M - -
P/E ratio 2021 -12,0x
Yield 2021 -
Sales 2022 41,5 M - -
Net income 2022 -46,1 M - -
Net cash position 2022 116 M - -
P/E ratio 2022 -12,5x
Yield 2022 -
Capitalization 566 M 566 M -
EV / Sales 2021 16,6x
EV / Sales 2022 10,9x
Nbr of Employees 48
Free-Float 35,1%
More Financials
Company
Vaccitech plc, formerly Vaccitech Ltd, is a clinical-stage biopharmaceutical company. The Company is engaged in the discovery and development of immunotherapeutics and vaccines for the treatment and prevention of infectious diseases and cancer. The Company uses its platform to develop product candidates that targets immune responses against pathogens and tumor cells. The Company has pipeline of both clinical and... 
Read more
More about the company
All news about VACCITECH PLC
09/09Vaccitech to Present at Upcoming September Investor conferences
GL
09/07VACCITECH : Material Definitive Agreement (Form 8-K)
PU
09/07VACCITECH PLC : Entry into a Material Definitive Agreement (form 8-K)
AQ
09/07Subsidiary of Vaccitech plc Enters into a Lease Agreement with the Harwell Sc..
CI
09/07VACCITECH : Enesi pharma appoints elizabeth eagling-vose, mba, as senior vice pr..
AQ
08/31European ADRs Move Lower in Tuesday Trading
MT
08/12VACCITECH : Management's Discussion and Analysis of Financial Condition and Resu..
AQ
08/12VACCITECH : Reports Second Quarter 2021 Financial Results and Recent Corporate D..
PU
08/12VACCITECH PLC : Results of Operations and Financial Condition, Financial Stateme..
AQ
08/12VACCITECH : Earnings Flash (VACC) VACCITECH (UK) LIMITED Reports Q2 Revenue $35,..
MT
08/12VACCITECH : Reports Second Quarter 2021 Financial Results and Recent Corporate D..
AQ
08/12Vaccitech plc Reports Unaudited Consolidated Earnings Results for the Second ..
CI
07/08VACCITECH : to Present at the William Blair Biotech Focus Conference 2021
AQ
07/06ARBUTUS BIOPHARMA : Partners With Vaccitech for Phase 2a Trial of Potential Chro..
MT
07/06ARBUTUS BIOPHARMA CORP : Other Events, Financial Statements and Exhibits (form 8..
AQ
More news
News in other languages on VACCITECH PLC
08/31Les ADR européens en baisse mardi
More news
Analyst Recommendations on VACCITECH PLC
More recommendations
Chart VACCITECH PLC
Duration : Period :
Vaccitech plc Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends VACCITECH PLC
Short TermMid-TermLong Term
TrendsBullishNeutralNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 5
Last Close Price 16,50 $
Average target price 24,50 $
Spread / Average Target 48,5%
EPS Revisions
Managers and Directors
William Enright Chief Executive Officer & Director
Georgy Egorov Chief Financial Officer
Robin Wright Chairman
Thomas G. Evans Chief Scientific Officer
Meg Marshall Chief Medical Officer
Sector and Competitors
1st jan.Capi. (M$)
VACCITECH PLC0.00%566
MODERNA, INC.321.80%177 867
LONZA GROUP AG36.36%62 278
IQVIA HOLDINGS INC.43.91%49 407
CELLTRION, INC.-25.63%31 021
SEAGEN INC.-12.32%27 940